News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,273 Results
Type
Article (87413)
Company Profile (739)
Press Release (770103)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232769)
Career Advice (4143)
Deals (39873)
Drug Delivery (144)
Drug Development (91175)
Employer Resources (205)
FDA (18253)
Job Trends (17422)
News (396851)
Policy (39843)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (120)
Alliances (56794)
ALS (153)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (312)
Approvals (18366)
Artificial intelligence (467)
Autoimmune disease (155)
Automation (31)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (538)
Cancer (4275)
Cardiovascular disease (301)
Career advice (3568)
Career pathing (41)
CAR-T (289)
CDC (36)
Celiac Disease (1)
Cell therapy (760)
Cervical cancer (29)
Clinical research (76103)
Collaboration (1603)
Company closure (4)
Compensation (990)
Complete response letters (64)
COVID-19 (2927)
CRISPR (85)
C-suite (732)
Cystic fibrosis (143)
Data (5407)
Decentralized trials (2)
Denatured (73)
Depression (114)
Diabetes (340)
Diagnostics (6976)
Digital health (23)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (251)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (197)
Earnings (97997)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (132799)
Executive appointments (824)
FDA (20617)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1269)
Gene editing (183)
Generative AI (46)
Gene therapy (601)
GLP-1 (931)
Government (5323)
Grass and pollen (4)
Guidances (276)
Healthcare (20778)
HIV (43)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (267)
Immuno-oncology (58)
Indications (80)
Infectious disease (3146)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (95)
Intellectual property (198)
Interviews (816)
IPO (17808)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (582)
Lymphoma (331)
Machine learning (41)
Management (66)
Manufacturing (714)
MASH (159)
Medical device (14421)
Medtech (14451)
Mergers & acquisitions (22742)
Metabolic disorders (1062)
Multiple sclerosis (149)
NASH (22)
Neurodegenerative disease (327)
Neuropsychiatric disorders (79)
Neuroscience (2891)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5079)
Now hiring (65)
Obesity (520)
Opinion (325)
Ovarian cancer (150)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (394)
Patient recruitment (414)
Peanut (56)
People (66277)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23595)
Phase 2 (33119)
Phase 3 (24813)
Pipeline (4280)
Policy (283)
Postmarket research (3544)
Preclinical (10586)
Press Release (72)
Prostate cancer (203)
Psychedelics (51)
Radiopharmaceuticals (278)
Rare diseases (792)
Real estate (7422)
Recruiting (80)
Regulatory (28227)
Reports (63)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (224)
Series B (160)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (122)
Vaccines (998)
Venture capital (91)
Weight loss (338)
Women's health (71)
Worklife (22)
Date
Today (3)
Last 7 days (472)
Last 30 days (1737)
Last 365 days (25253)
2026 (2379)
2025 (25543)
2024 (34033)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (288)
Arkansas (8)
Asia (51120)
Australia (9002)
California (9719)
Canada (2473)
China (1055)
Colorado (306)
Connecticut (389)
Delaware (295)
Europe (116899)
Florida (1256)
Georgia (254)
Hawaii (4)
Idaho (65)
Illinois (652)
India (56)
Indiana (445)
Iowa (21)
Japan (338)
Kansas (133)
Kentucky (25)
Louisiana (14)
Maine (59)
Maryland (1256)
Massachusetts (7303)
Michigan (244)
Minnesota (452)
Mississippi (5)
Missouri (78)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2549)
New Mexico (29)
New York (2550)
North Carolina (1410)
North Dakota (9)
Northern California (4770)
Ohio (257)
Oklahoma (18)
Oregon (51)
Pennsylvania (1869)
Puerto Rico (22)
Rhode Island (33)
South America (1658)
South Carolina (13)
South Dakota (1)
Southern California (3750)
Tennessee (58)
Texas (1358)
United States (33779)
Utah (209)
Vermont (1)
Virginia (168)
Washington D.C. (54)
Washington State (818)
West Virginia (2)
Wisconsin (82)
858,273 Results for "strm bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy
January 8, 2026
·
2 min read
Business
STRM.BIO Appoints Independent Director Minnie Mildwoff, to its Board of Directors
STRM.BIO today announced the appointment of Minnie Mildwoff, to its Board of Directors.
July 24, 2023
·
2 min read
Genetown
STRM.BIO Receives Extension of Grant to Advance In Vivo Gene Therapy Delivery Platform
STRM.BIO announced the continuation of their grant from the Bill & Melinda Gates Foundation to create novel technology platform capabilities for in vivo delivery of gene therapies being developed by the foundation.
October 3, 2023
·
1 min read
Business
STRM.BIO Appoints Independent Director Dawn Bell, PharmD, to its Board
STRM.BIO today announced the appointment of Dawn Bell , PharmD, to its Board of Directors.
May 17, 2023
·
2 min read
Genetown
STRM.BIO Presents First Preclinical Data on a Novel Bone Marrow/Hematopoietic Stem Cell-Targeted Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at ASH 2023
STRM.BIO presented the first preclinical data on their novel delivery platform that uses megakaryocyte-derived EVs to target hematopoietic stem/progenitor cells (HSPCs) in the bone marrow at the American Society of Hematology (ASH) annual meeting being held in San Diego, California, December 9 – 12, 2023.
December 11, 2023
·
4 min read
Drug Development
STRM.BIO to Present Preclinical Data on a Novel Bone Marrow/HSC-Targeted, Megakaryocyte-Derived Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at ASH 2023
STRM.BIO announced that it will present preclinical data on their novel delivery platform for in vivo gene therapy that uses megakaryocyte-derived EVs to target hematopoietic stem cells in the bone marrow at the 65th American Society of Hematology Annual Meeting being held in San Diego, California, December 9 – 12, 2023.
November 2, 2023
·
1 min read
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
October 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
January 27, 2026
·
2 min read
Business
STRM.BIO CEO Jonathan Thon, Ph.D. to Deliver the 2023 R. D. Zeigler Innovation Research Lecture Sponsored by the Versiti Blood Research Institute
STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles to deliver gene therapies and developing new therapeutics for rare blood diseases, announced that CEO Jonathan Thon, Ph.D. is the featured speaker at the 5th annual R. D. Zeigler Innovation Research Lecture Sponsored by the Versiti Blood Research Institute.
October 19, 2023
·
1 min read
Drug Development
STRM.BIO Presents Preclinical Data on a Novel Bone Marrow/HSPC-Targeted, Megakaryocyte-Derived Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at the Cell & Gene Meeting on the Mesa
STRM.BIO presented the first preclinical data on the company’s novel delivery platform for in vivo gene therapy that uses megakaryocyte-derived EVs to target bone marrow hematopoietic stem cells at the 2023 Cell & Gene Meeting on the Mesa being held in Carlsbad, California.
October 11, 2023
·
3 min read
1 of 85,828
Next
